Physician profile
Lauren E Kemp
NPI 1336691112
$3,818.03
in general payments reported to CMS, 2019-2025
20 companies · $830 in 2025
The $830 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $204 · 2023: $1,098 · 2024: $1,307 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,235.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,043.78 | 2021-2025 | Farxiga, Lokelma, Brilinta |
| Merck Sharp & Dohme LLC | $670.68 | 2022-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $479.23 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $433.48 | 2021-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $238.57 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $208.62 | 2023-2025 | Lifevest |
| Medtronic, INC. | $122.01 | 2023-2025 | Symplicity G3, Micra |
| Novartis Pharmaceuticals Corporation | $112.20 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.85 | 2023 | Jardiance |
| Cvrx, INC. | $67.86 | 2024 | Barostim Neo System |
| Novo Nordisk INC | $57.15 | 2023 | Wegovy |
| Atricure, INC. | $35.96 | 2023 | |
| Inspire Medical Systems, INC. | $28.78 | 2025 | Inspire |
| Silk Road Medical, INC. | $27.90 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.95 | 2025 | Nc Trek Neo |
| Allergan, INC. | $24.43 | 2022 | |
| Lilly USA, LLC | $24.23 | 2025 | Zepbound |
| Scpharmaceuticals INC. | $18.30 | 2023 | |
| Itamar Medical INC | $14.89 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Kemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.